Tolfenamic acid inhibited the transcription factor Sp1, which reduced the transcription of APP and BACE1 in Pb-exposed human neuroblastoma SH-SY5Y cells and decreased Aβ accumulation in APP transgenic mice [11, 17]. The gene discussed is APP; the disease is neuroblastoma.